DJIA 16,408.54 -16.31 -0.10%
NASDAQ 4,095.52 0.00 0.00%
S&P 500 1,864.85 2.54 0.14%
market minute promo

4.15 -0.03 (-0.72%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

PLX $4.15 -0.72%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $4.13
Previous Close $4.18
Daily Range $4.13 - $4.22
52-Week Range $3.70 - $5.81
Market Cap $388.4M
P/E Ratio 13.83
Dividend (Yield) $0.00 (0.0%)
Volume 84,569
Average Daily Volume 189,180
Current FY EPS -$0.08

Sector

Healthcare

Industry

Drugs

Protalix BioTherapeutics, Inc. (PLX) Description

A clinical stage biopharmaceutical company that is focused on developing and manufacturing recombinant therapeutic proteins that are produced through its proprietary plant cell system. Website: http://www.protalix.com/

News & Commentary Rss Feed

Sector Update: Healthcare Shares Edging Higher in Pre-Bell Trade

Sector Update: Healthcare

Protalix Biotherapeutics - A Compelling Buy Due To Validation Of Oral Protein Delivery Technology

Protalix Offers Update on Health Canada Evaluation, Says Manufacturing Facility Utilizing ProCellEx

Protalix Offers Update on Health Canada Evaluation, Says Manufacturing Facility Utilizing ProCellEx Deemed Acceptable by EMA, FDA, IMH, ANVISA, TGA

3 High-Risk, High-Reward Biotech Stocks for Long Term Investors

Everyone wants to get rich, but investing in the wrong developmental companies can have disastrous consequences. Here are three companies with game-changing potential that have yet to hit their stride -- and may payoff in the long run.

2 Biotech Stocks Under $10 to Watch

Oppenheimer Sees Five Biotech Stocks to Buy With Potential 50% Upside, or More

Protalix BioTherapeutics Inc. Enters Oversold Territory - Tale of the Tape

Protalix BioTherapeutics Inc. Enters Oversold Territory - Tale of the Tape

Will Omnivision (OVTI) Beat Earnings Estimates? - Analyst Blog

Maxim Prices Senior Notes - Analyst Blog

See More PLX News...

PLX's Top Competitors

PLX $4.15 (-0.72%)
Current stock: PLX
AMGN $115.46 (-0.07%)
Current stock: AMGN
GILD $70.00 (1.04%)
Current stock: GILD
BIIB $290.54 (-0.32%)
Current stock: BIIB